Sensor-augmented pump therapy in very young children with type 1 diabetes: an efficacy and feasibility observational study
| العنوان: | Sensor-augmented pump therapy in very young children with type 1 diabetes: an efficacy and feasibility observational study |
|---|---|
| المؤلفون: | Giuseppe Chiumello, Giulio Frontino, Ivana Rabbone, Franco Meschi, Riccardo Bonfanti, Elisa Gioia, Gian Vincenzo Zuccotti, Sabrina Sicignano, Franco Cerutti, Clara Bonura, Roseila Battaglino, Andrea Scaramuzza, Valeria Favalli, Andrea Rigamonti |
| المساهمون: | Frontino, G, Bonfanti, R, Scaramuzza, A, Rabbone, I, Meschi, F, Rigamonti, A, Battaglino, R, Favalli, V, Bonura, C, Sicignano, S, Gioia, E, Zuccotti, Gv, Cerutti, F, Chiumello, G., Frontino, G., Bonfanti, R., Scaramuzza, A., Rabbone, I., Meschi, F., Rigamonti, A., Battaglino, R., Favalli, V., Bonura, C., Sicignano, S., Gioia, E., Zuccotti, G. V., Cerutti, F. |
| سنة النشر: | 2012 |
| مصطلحات موضوعية: | Blood Glucose, Male, Insulin pump, medicine.medical_specialty, endocrine system diseases, Endocrinology, Diabetes and Metabolism, Biosensing Techniques, Hypoglycemia, Drug Administration Schedule, Insulin Infusion Systems, Endocrinology, Rating scale, Internal medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, In patient, Child, Retrospective Studies, Glycated Hemoglobin, Type 1 diabetes, Dose-Response Relationship, Drug, business.industry, nutritional and metabolic diseases, Mean age, medicine.disease, Medical Laboratory Technology, Diabetes Mellitus, Type 1, Treatment Outcome, Italy, Child, Preschool, Physical therapy, Feasibility Studies, Female, Observational study, business |
| الوصف: | Background: Efficacy and feasibility of sensor-augmented pump (SAP) therapy were evaluated in very young children with type 1 diabetes (T1D). Subjects and Methods: SAP (Dexcom [San Diego, CA] Seven Plus™ usage combined with insulin pump) therapy was retrospectively evaluated in 28 children (15 boys) younger than 7 years (mean age, 5.8±1.2 years; range, 3–7 years), with T1D. Glycosylated hemoglobin (HbA1c) was evaluated at baseline and at the end of the study, as were efficacy and feasibility of the system, using a rating scale (with 3 being the most positive). Results: SAP has been used for at least 6 months by 85% of patients, with an overall good satisfaction (92%). The greatest perceived benefit was the reduced fear of hypoglycemia (score of 3, 81%). HbA1c significantly improved only in patients with baseline HbA1c >7.5% (P=0.026). Conclusions: SAP therapy is effective and feasible in preschool children with T1D. In patients with high HbA1c at baseline it provide a 0.9% decrease, sustained for... |
| اللغة: | English |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::969f08f4be029f3aa27ed263448cf98fTest http://hdl.handle.net/2318/123824Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....969f08f4be029f3aa27ed263448cf98f |
| قاعدة البيانات: | OpenAIRE |
| الوصف غير متاح. |